Abstract:Introduction: In Germany, commercial CAR-T cell therapies are registered with the German Registry for Stem Cell Transplantation (DRST), which is the National partner organization of the EBMT registry. Here, we present the first risk factor analysis of standard-ofcare (SOC) CAR-T cell therapies for large B-cell lymphoma (LBCL) based on DRST data.
“…Real-world data do not currently exist for liso-cel owing to its very recent approval. Authors from the German Register for Stem Cell Transplantation (DRST) presented a first risk factor analysis of standard-of-care (SOC) CAR-T cell therapies for DLBCL (27). A total of 267 patients were included, who received axi-cel (137) or tisa-cel (130) for treatment of DLBCL until December 2020.…”
Section: (See Table II and Table Iii)mentioning
confidence: 99%
“…Vol. 2(1), [21][22][23][24][25][26][27][28][29][30][31][32][33]2022 SCEND-CLL-044 is assessing CAR-T cell therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma (NCT03331198).…”
Section: Ongoing Trials Of Cd19 Car-t Cellmentioning
“…Real-world data do not currently exist for liso-cel owing to its very recent approval. Authors from the German Register for Stem Cell Transplantation (DRST) presented a first risk factor analysis of standard-of-care (SOC) CAR-T cell therapies for DLBCL (27). A total of 267 patients were included, who received axi-cel (137) or tisa-cel (130) for treatment of DLBCL until December 2020.…”
Section: (See Table II and Table Iii)mentioning
confidence: 99%
“…Vol. 2(1), [21][22][23][24][25][26][27][28][29][30][31][32][33]2022 SCEND-CLL-044 is assessing CAR-T cell therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma (NCT03331198).…”
Section: Ongoing Trials Of Cd19 Car-t Cellmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.